THE LONG VIEW

The research journal.

Company research on Miami International Holdings (MIAX), including the business, investment thesis, risks, and valuation.

MIAX · Research: 2026-11-05
MIAX NYSE · Financial Exchanges & Market Data

Miami International Holdings

HoldMedium-High risk · 55/100 valuation confidence

Price snapshot: 2026-11-04 · Research: 2026-11-05 · Saved analysis, not live market data

Ratings and fair values are independent, dated research opinions—not personalized investment advice. Disclaimer

Reference price$34.972026-11-04
Weighted fair value$35.90Probability-weighted model
Return to fair value+2.7%Not an annualized return
Business quality78.9/100Tier Tier B · price independent

What is the price assuming?

USD per share

The reference price is below the probability-weighted fair value.

Dashed marker: reference price $34.97. Scenario values are present fair values, not dated price targets.

See the assumptions behind each scenario

Bear · 30%

Share drifts toward 15–16%, RPC <$0.095, industry volumes weaken, futures losses persist and dilution continues

RPC pressure, futures losses and dilution justify raising the bear weight to 30%

Base · 50%

Options share ~17%, RPC near ~$0.10, access/data fees grow, operating leverage offsets only gradually improving futures losses and moderate dilution

Q3 margins support normalized earnings if RPC and diluted shares stabilize

Bull · 20%

Rising profitable options volumes, successful services and real futures retail adoption at improving net capture; dilution moderates

Successful product economics are unproven; weight remains limited to 20%
Strong Buy zone≤ $23.10
Buy zone> $23.10–$28.72
Avoid above> $39.89

FolioFacts zones calculated from the saved fair and bear values at the dated reference price. Live zones can change with research.

The business behind the valuation.

MIAX has become a scaled U.S. options venue group. Its 17.4% Q3 2026 options share and 76.8% options segment adjusted EBITDA margin provide evidence of a viable exchange technology and liquidity franchise against Cboe, Nasdaq and NYSE options venues. The business can compound earnings if growing industry volumes, connectivity and data revenue translate into superior per-share economics.

Business drivers

  • Business durability and economics. High incremental margins and strong core exchange economics, offset by transaction dependence
  • Moat and competitive position. Meaningful options scale, technology and licenses, but multi-homing and price competition limit switching costs
  • Growth runway and durability. Options share gains plus futures/international optionality

What could weaken the thesis

  • Options share. Toward 15–16%
  • Options RPC. Persistent <$0.095
  • Options ADV. Multi-quarter downturn

The financial picture.

USD millions

Revenue

Reported FY totals, current FY quarters and cumulative YTD are grouped separately.

Completed fiscal years

Scale within group: $440M

FY2024
$275.6M
FY2025
$430.5M

Current fiscal year · standalone quarters

Scale within group: $160M

Q1 FY2026
$128.59M
Q2 FY2026
$141.11M
Q3 FY2026
$131.01M

Current fiscal year · cumulative YTD

Scale within group: $420M

H1 FY2026
$269.71M
9M FY2026
$400.72M

Cash flow vs. stock-based compensation

Completed FY, standalone current-year quarters and cumulative YTD. No TTM figures.

Free cash flowStock-based compensation

Completed fiscal years

Each row covers a completed fiscal year. Scale within this group: $160M.

FY2024
$84.7M
$43.6M
SBC / FCF 51.5%
FY2025
$145M
$57.6M
SBC / FCF 39.7%

Current fiscal year · standalone quarters

Each row covers an independent quarter; derived cash flow is labeled. Scale within this group: $8.8M.

Q1 FY2026
Not reported
—
$8.67M
SBC / FCF Not reported
Q2 FY2026
Not reported
—
$7.29M
SBC / FCF Not reported
Q3 FY2026FCF calculated
$1M
$7.54M
SBC / FCF 753.9%

Current fiscal year · cumulative YTD

YTD totals overlap the quarters above and must not be added to them. Scale within this group: $180M.

H1 FY2026FCF calculated
$150.56M
$15.96M
SBC / FCF 10.6%
9M FY2026FCF calculated
$169.32M
$23.5M
SBC / FCF 13.9%

Each annual, quarter and YTD group uses a separate scale. SBC / FCF is a same-period comparison, not a literal employee cash payment. N/M means FCF is zero or negative (or SBC is negative); missing is not zero. Issuer FCF definitions may vary.

Latest period 9M FY2026Cash $698.85MDebt $1.5M

Only completed fiscal years and currently open fiscal-year quarters/YTD appear in charts. Standalone quarters and cumulative YTD are separate; missing is never zero. Legacy TTM rows remain in archival source text. The full financial profile below preserves definitions, accounting caveats, and period-end balance details.

How the business scores.

Quality / 100
Business durability and economics25% weight
80
Moat and competitive position25% weight
78
Growth runway and durability20% weight
83
Financial quality and balance sheet15% weight
80
Management, governance and capital allocation15% weight
72
Opportunity score at research price53.3/100

This score uses the saved price and research fundamentals. Creator Watchlist calculates the current score and rank using verified market prices.

What would change the view?

Watch the evidence behind the thesis, not just the ticker.

01Options share

Would support the thesis

Sustained ≥17% with good capture

Would weaken the thesis

Toward 15–16%

Affects: Moat / EPS
02Options RPC

Would support the thesis

Stable ≥$0.10

Would weaken the thesis

Persistent <$0.095

Affects: Highest-priority valuation sensitivity
03Options ADV

Would support the thesis

Durable industry growth

Would weaken the thesis

Multi-quarter downturn

Affects: Revenue growth
04Access/data revenue

Would support the thesis

Member expansion, Jan. 2027 fee increase sticks

Would weaken the thesis

One-time or customer pushback

Affects: Revenue mix
05Dilution/SBC

Would support the thesis

EPS growth catches earnings growth

Would weaken the thesis

Continued double-digit dilution

Affects: Per-share compounding
06Futures

Would support the thesis

Multiple brokers drive real volume and positive economics

Would weaken the thesis

Continuing high subsidies without users

Affects: Optionality
07Proposed binary products

Would support the thesis

Regulatory approval and monetization

Would weaken the thesis

Delayed approval, weak demand

Affects: Optionality, not base EPS
08Cash/investment discipline

Would support the thesis

Product returns and prudent spending

Would weaken the thesis

Overinvestment/acquisitions

Affects: Valuation confidence
09Competitors

Would support the thesis

Product-led capture gains

Would weaken the thesis

Aggressive fee pressure

Affects: Moat and margins

Go deeper, when you need to.

Investment Thesis

MIAX has become a scaled U.S. options venue group. Its 17.4% Q3 2026 options share and 76.8% options segment adjusted EBITDA margin provide evidence of a viable exchange technology and liquidity franchise against Cboe, Nasdaq and NYSE options venues. The business can compound earnings if growing industry volumes, connectivity and data revenue translate into superior per-share economics.

The difficult question is not whether MIAX can process volume efficiently; it is whether it can retain flow without cutting revenue per contract too much, and whether diluted EPS can compound after SBC, warrants and other share issuance. Q3 revenue per contract of $0.098, versus Q2's exceptional $0.124, illustrates the risk. Futures, international exchanges and new proprietary contracts are option value, not currently the foundation of earnings.

What the Market May Be Mispricing

Debate Current Assessment
Is MIAX still a marginal options exchange? No: 17.4% U.S. options share and substantial core profitability establish meaningful scale
Is Q2 revenue per options contract the new normal? No: Q3 $0.098 and management's ~$0.10 reset are better near-term anchors
Does adjusted EBITDA growth translate to EPS? Not fully: Q3 adjusted EBITDA +47.5% vs adjusted EPS +7%
Should MIAX cash be added on top of a P/E valuation? No: a whole-equity earnings multiple already includes cash value
Should futures/new proprietary products command a high premium? Only after volume, positive capture and regulatory/operating outcomes are demonstrated
The business and how it makes money

MIAX operates multiple regulated venues using proprietary exchange infrastructure. Transaction fees, exchange connectivity, market data and listings support its revenues; net revenue after liquidity payments and other transaction costs, not gross fees, better captures the operating economics.

Segment / Platform Role Q3 Net Revenue Q3 Adjusted EBITDA Assessment
Options — MIAX Options/Pearl/Emerald/Sapphire U.S. multi-listed options $112.6M (+19% YoY) $86.5M Main profit pool, 76.8% EBITDA margin
Equities — Pearl Equities U.S. cash equities $6.7M (+53% YoY) $1.0M Small but improving
Futures / Bloomberg / agricultural Futures marketplace/products $5.0M (+4% YoY) -$8.4M Early-stage investment and incentives
International — BSX / TISE Listings and market infrastructure $6.1M (+11% YoY) $2.3M Small profitable diversification
Corporate/other Consolidating activity $0.6M — Not a separate growth engine

Options accounted for roughly 86% of Q3 net revenue. Dorman Trading's additional FCM capital and OCC clearing membership support broker access to MIAX futures; neither proves customer adoption or sustainable positive pricing.

On November 3, MIAX announced filings proposing binary Bloomberg-index options, with a potential 2027 introduction subject to SEC review, and company-KPI binary options without a firm launch date. No unapproved product revenue is assumed in the base model.

Business Takeaway

The core options franchise already finances the company. The adjacent businesses offer diversification but still require validated demand, liquidity and economic returns.

Industry and market context

Options industry growth remains supportive. MIAX's Q3 options average daily volume reached approximately 11.1 million contracts, up 15.2% YoY, and market share increased to 17.4% versus 17.2% a year earlier and 16.5% sequentially in Q2. The sequential rebound is useful; the small YoY share gain means industry trading growth, rather than a dramatic competitive shift, still explains much of the improvement.

Market-Share Analysis

Direct competitors span multiple U.S. options venues; consistent, current market-share figures for all venues were not available, so relative competitive positions are compared below rather than asserting incompatible market-share estimates.

Company / Platform Primary Position Relative Scale Growth Direction Investment Relevance
MIAX U.S. listed options, with developing equity and futures venues 17.4% Q3 2026 U.S. options share Modest YoY share gain Core options economics drive valuation; futures remain an investment
Cboe Direct U.S. listed-options competitor Broader product and proprietary-IP ecosystem Strong Primary direct exchange competitor
Nasdaq U.S. listed options and equities More diversified group Stable Direct options competitor and secondary valuation anchor
NYSE / ICE U.S. options and equities venues; ICE also operates futures Broad, diversified parent Strong Direct U.S. options competitor, diversified valuation anchor
BOX / MEMX Overlapping U.S. exchange venues Smaller competitors in the MIAX analysis Mixed Fee competition affects capture
CME Futures market Entrenched futures liquidity network Strong Futures benchmark, not a listed-options share comparator

MIAX reported share observations across different periods and products (preserved from the earnings review):

Product / Definition Current Period Prior Period Interpretation
MIAX U.S. listed-options share, Q3 2026 17.4% 17.2% Q3 2025 Share improvement, but modest
MIAX U.S. listed-options share, Q3 vs Q2 2026 17.4% 16.5% Q2 2026 Sequential recovery
MIAX U.S. equities market share, earlier YTD 2026 ~0.8% ~1.1% prior-year period Weak adjacency

A consistently defined, current U.S.-listed-options share table across Cboe, Nasdaq, NYSE, BOX and MEMX was not available from the source set used, so no incompatible peer figures are implied. Direct competitors are separated from futures-only competitors in the following section.

Industry Takeaway

The options franchise has genuine relevance and a sizable transaction market. Volume growth without retained per-contract capture, however, cannot guarantee earnings growth.

Competition and the moat

Competitive Landscape

Competitor Market Share Positioning Advantages vs. Company Disadvantages vs. Company Current Direction
Cboe N/A on a directly comparable single-group basis in this analysis Direct segments: U.S. listed options and overlapping derivatives Broader product/IP ecosystem and global scale MIAX can be more agile and focused Strong
Nasdaq N/A on a directly comparable single-group basis in this analysis Direct segments: U.S. options and equities exchanges Substantially more diversified MIAX has strong purpose-built options architecture Stable
NYSE / ICE N/A on a directly comparable single-group basis in this analysis Direct segments: U.S. options/equities venues; parent futures not equivalent Dominant data, futures and clearing assets MIAX has gained meaningful options share despite smaller scale Strong
CME N/A — futures market differs Direct segment: competing futures contracts; not an options-share comparator Extraordinary futures liquidity/network effects Bloomberg partnership gives MIAX differentiated products Strong
BOX / MEMX N/A Direct: overlapping U.S. exchange venues Fee competition remains intense MIAX has greater options scale Mixed

Moat Assessment

MIAX's most credible moat is its purpose-built exchange technology and the liquidity ecosystem accumulated around it. Management argues that its low-latency architecture, deterministic performance and risk controls allow market makers to quote more aggressively. Exchange rules can often be copied; the full technological implementation and liquidity network are harder to replicate.

Regulatory licenses and member connectivity are additional barriers, but not absolute ones. Sophisticated trading firms multi-home across venues and move flow based on economics.

Moat direction: Stable to modestly strengthening.

Competitive Takeaway

MIAX has built a real competitive position in options, but I would not characterize it as having the same network-effect depth as CME's futures complex or the breadth of ICE, Cboe or Nasdaq. The moat is good enough to support attractive economics, not good enough to eliminate price competition.

Full financial profile and accounting context

Q3 consolidated net revenue was $131.0M (+19.7% YoY) and adjusted EBITDA $70.8M (+47.5%), lifting adjusted margin to 54.0% from roughly 44%. Adjusted operating expense declined approximately 2% to $60.3M. This is strong operating leverage; the GAAP period comparison includes unusual IPO-period costs and other discrete adjustments.

Historical Financials

Financial reporting periods follow the issuer's fiscal year: completed FY rows plus standalone current-year quarters and cumulative H1/9M for FY2026. Revenue is issuer net revenue (revenues less cost of revenues), not the gross US-GAAP revenues tagged in SEC company facts. FCF is operating cash flow minus both purchases of property/equipment and capitalized internal software. Q3 FCF is derived by subtracting H1 from 9M. Q1 and Q2 standalone FCF remain N/D pending source-verified matching quarterly cash outflows. SBC is the same-period issuer-disclosed amount; cash is a period-end balance. Missing values are N/D, not zero. Unit: USD millions. Data extracted from SEC-tagged filings as of 2026-11-07. Company-specific FCF definitions and acquisition effects may require further reconciliation.

Period Revenue Growth Gross Margin Operating Margin FCF FCF Margin SBC Diluted Shares Cash Debt
FY2024 $275.6M +18.6% N/D N/D FCF ~$84.7M (earlier provider definition) N/D $43.6M ~74.6M adjusted N/D N/D
FY2025 $430.5M +56.2% N/D N/D FCF ~$145M (earlier provider definition) N/D $57.6M ~90.6M adjusted N/D N/D
Q1 FY2026 $128.593M (derived: H1 less Q2 net revenue) N/D N/D N/D N/D N/D $8.673M 109.154M $550.786M N/D
Q2 FY2026 $141.113M +34.8% N/D 19.7% N/D N/D $7.290M 110.714M $660.462M N/D
H1 FY2026 $269.706M +37.2% N/D N/D $150.564M (derived: CFO less PPE capex and capitalized software) 55.8% $15.963M 109.944M $660.462M N/D
Q3 FY2026 $131.009M +19.7% N/D 36.0% $18.760M (derived: 9M less H1 FCF) 14.3% $7.539M 110.799M $698.854M ~$1.5M
9M FY2026 $400.715M +30.9% N/D N/D $169.324M (derived: CFO less PPE capex and capitalized software) 42.3% $23.502M 110.249M $698.854M ~$1.5M

Supplemental historical reporting context (retained)

Supplemental earnings-release presentation, preserving adjusted EBITDA/margin and original cash-flow classifications:

Period Net Revenue Growth Adjusted EBITDA / Margin Cash Flow SBC Diluted Shares Cash / Debt
FY2024 $275.6M +18.6% Historical FCF ~$84.7M (earlier provider definition) $43.6M ~74.6M adjusted Historical
FY2025 $430.5M +56.2% $199.1M / 46.2% FCF ~$145M (earlier provider definition) $57.6M ~90.6M adjusted Historical
H1 2026 $269.7M +37.2% ~$142.9M / ~53% $150.564M FCF (calculated, includes software capex) $15.963M Q2 adj. diluted ~110.7M ~$660M / ~$1.5M
Q3 2026 $131.0M +19.7% $70.8M / 54.0% $18.760M FCF (derived from 9M less H1 cash flows) $7.539M 110.8M adjusted $698.9M / $1.5M
9M 2026 $400.7M +30.9% ~$213.7M / ~53.3% $206.708M OCF / $169.324M FCF including software capex $23.502M ~110.2M GAAP diluted $698.9M / $1.5M

SBC disclosure: Q3 2026 share-based compensation was $7.539M, versus $29.098M in Q3 2025; nine-month 2026 SBC was $23.502M, versus $48.007M in 9M 2025. The prior-year quarter included accelerated equity compensation related to the IPO. Amounts are from MIAX's Q3 2026 earnings reconciliation and 10-Q; these costs remain economically relevant even when excluded from adjusted results.

2026 cash-flow reconciliation ($M): The company publishes cumulative cash-flow statements; the Q3 cash-flow entries below are calculated as 9M less H1, not separately reported quarterly cash-flow line items. FCF consistently subtracts both property/equipment capital expenditures and capitalized internal software from operating cash flow. SBC is separately reported for Q3.

Cash-flow item H1 2026 (6M) 9M 2026 (9M) Q3 2026 (9M minus H1)
Operating cash flow $183.642M $206.708M $23.066M
Capital expenditures $27.992M $29.438M $1.446M
Capitalized internal software $5.086M $7.946M $2.860M
Free cash flow (calculated) $150.564M $169.324M $18.760M
Stock-based compensation $15.963M $23.502M $7.539M (reported Q3)

Time-period warning: H1 and 9M are overlapping cumulative periods; Q3 is a three-month standalone period. Do not compare Q3's dollar bars directly with full-year or year-to-date totals. FY2024–FY2025 FCF values retain an earlier provider definition and should not be assumed comparable with this 2026 capex-inclusive definition.

Nine-month free cash flow shown here deducts $29.438M capital spending and $7.946M capitalized internal software from $206.708M operating cash flow, yielding $169.324M (~42.3% net revenue margin). Previous annual FCF figures use a different provider convention and should not be treated as identical definitions.

Q3 adjusted earnings $50.1M (+25%) turned into adjusted EPS $0.45 (+7%), because adjusted diluted shares increased from 96.1M to 110.8M (~15%). The large historical basic-share increase is partly capital-structure/IPO/warrant conversion related, not all continuing employee compensation. Nevertheless, SBC and future diluted share growth matter. GAAP 9M profits are inflated by a tax valuation allowance reversal and MIAXdx sale gain, while a $30M litigation settlement is a large discrete charge; avoid valuing the stock using unnormalized GAAP profits.

Financial Takeaways

MIAX converts scale into margins and cash, has very little funded debt, and can afford to invest. Future per-share value creation still depends on stabilizing RPC, minimizing dilution and earning satisfactory returns on futures capital.

Financial direction: Improving operations, mixed per-share value creation.

Valuation method and comparable companies

Current Valuation

Re-underwritten November 5, 2026.

Metric Value
Price Snapshot $34.97, Nov. 4 regular-session close
Shares outstanding (basic, approx.) 100.06M
Market Capitalization ~$3.50B ($34.97 × 100.06M)
Cash / funded debt, Sept. 30 $698.9M / $1.5M
Enterprise Value ~$2.80B, simplified equity less cash plus funded debt (not a fully adjusted EV)
Annualized Q3 adjusted EBITDA ~$283.2M
EV / Q3 annualized adjusted EBITDA ~9.9×
Annualized 9M adjusted EPS ~$1.80 (illustrative, not company guidance)
Price / annualized 9M adjusted EPS ~19.4×
Annualized 9M FCF after software capex ~$225.8M, ~15.5× price/FCF

The annualized figures are not forward guidance and differ from vendor TTM and conventional GAAP metrics. Cash excludes restricted/customer-clearing cash and the simple EV bridge excludes possible debt/lease/investment adjustments. P/E scenario fair values value the entire equity including cash; do not add net cash again.

Comparable Company Analysis

November 4 same-provider research cross-check, with differing business mix and source definitions. MIAX's internally calculated annualized and adjusted metrics are not strictly equivalent to the following vendor-reported metrics.

Company Relevance Public / Private Forward P/E Price / FCF EV / EBITDA Growth / Margin / Risk Context
MIAX Core exchange subject; annualized adjusted research metrics Public ~19.4× EPS run-rate ~15.5× annualized 9M FCF ~9.9× Q3 annualized adjusted EBITDA Strong core options margins and liquidity; RPC and dilution remain material risks
Cboe Direct listed-options peer Public 22.8× 14.2× 17.2× Direct options competitor; broader product and intellectual-property base
ICE Listed-exchange segment competitor and diversified valuation anchor Public 20.4× 18.5× 17.3× Diversified exchange group; listed-options segment is only one activity
Nasdaq U.S. options/equities competitor and diversified anchor Public 24.0× 27.0× 20.0× Diversified options/equities venue and technology group
CME Futures-only network-effects benchmark Public 23.8× 25.5× 22.6× Futures-network valuation benchmark, not a listed-options share peer

These larger operators generally deserve higher multiples for proprietary products, liquidity networks and/or diversification. Do not force their multiple average on MIAX.

Valuation Scenarios

Normalized 2027 adjusted diluted EPS scenarios.

Scenario Key Assumptions 2027 EPS Multiple Fair Value Probability Probability Rationale Return From Price Snapshot
Bear Share drifts toward 15–16%, RPC <$0.095, industry volumes weaken, futures losses persist and dilution continues $1.50 14× $21.00 30% RPC pressure, futures losses and dilution justify raising the bear weight to 30% -40.0%
Base Options share ~17%, RPC near ~$0.10, access/data fees grow, operating leverage offsets only gradually improving futures losses and moderate dilution $2.00 19× $38.00 50% Q3 margins support normalized earnings if RPC and diluted shares stabilize +8.7%
Bull Rising profitable options volumes, successful services and real futures retail adoption at improving net capture; dilution moderates ~$2.30 ~23× $53.00 20% Successful product economics are unproven; weight remains limited to 20% +51.6%
Probability-Weighted 30% Bear / 50% Base / 20% Bull $35.90 100% Weighted average of the three scenarios +2.7%

Arithmetic: 0.30 × $21 + 0.50 × $38 + 0.20 × $53 = $35.90.

Changes from the preceding underwriting: Bear falls $22.50 → $21 because lower RPC and sustained dilution increase downside earnings/multiple sensitivity. Base $39 → $38 because $2.00 normalized EPS is retained but its multiple is cut 19.5× → 19×. The EPS is retained deliberately after Q3: improved operating margins and lower expense guidance still support earnings growth from the annualized ~$1.80 nine-month adjusted EPS baseline, provided capture stabilizes and dilution slows. Bull $53 remains unchanged: ~$2.30 EPS and stronger proprietary-product economics are plausible but unproven, so its weight stays 20%. Bear weight rises 25% → 30%; base weight falls 55% → 50%.

The prior P/W value $37.68 is therefore cut to $35.90 (-4.7%). At today's dated research reference close, the old $37.68 value would imply ~7.7% upside, whereas the new valuation implies ~2.7%. That separates the effect of a higher stock price from the fundamental model downgrade.

Valuation Takeaway

  • Primary valuation method: Scenario P/E multiples applied to normalized 2027 adjusted diluted EPS.
  • Valuation refresh date / changes vs. previous valuation (including reasons for unchanged inputs): 2026-11-05; bear $22.50 → $21, base $39 → $38, bull retained at $53, and probability-weighted fair value $37.68 → $35.90, as explained above.
  • Cross-check methods: Annualized Q3 adjusted EBITDA and EV/EBITDA, annualized nine-month adjusted EPS and P/E, annualized nine-month FCF and price/FCF, and exchange peers.
  • Key valuation dependencies: Options market share, ~$0.10 per-contract capture, diluted-share growth, futures losses and returns on new products.
  • Valuation confidence / Risk Level: 55/100 / Medium-High.
  • Margin-of-safety conclusion: At the November 4 reference close of $34.97, $35.90 weighted fair value provides only ~2.7% modeled upside against ~40% bear-case downside.

Quality 78.9 / Tier B unchanged. Valuation confidence 55/100, down from 58, with Medium-High risk. MIAX has a valuable options franchise, but at $34.97 there is little modeled weighted upside and significant downside under a pricing and dilution stress. This report sets no live Buy/Hold zones, rankings or Opportunity Score; FolioFacts owns those functions.

Management and capital allocation

Management deserves credit for scaling its options venues and reducing FY2026 adjusted operating expense guidance to $254–257M from $260–270M, while Q3 revenue and margin advanced. However, planned marketing, quoting support, hiring and technology costs are expected to rebound in Q4 and into 2027; Q3 should not be treated as a permanent zero-growth expense base.

Updated FY2026 guidance also calls for $30–32M SBC, $43–46M capex (including software capitalization), and a 26–28% adjusted tax rate. Dorman received a $40M capital increase to support greater futures activity and clearing. Management favors reinvestment and selective deals over near-term distributions; large cash balances must therefore be evaluated alongside potential product-launch returns and dilution.

The post-quarter binary-option plans and commentary about perpetuals are opportunities, not approved profit streams. Management described customer demand, regulatory clarity and economic returns as necessary decision gates before committing to new products.

Management Takeaway

Above-average operating execution, but new-market capital allocation and consistent per-share growth have yet to be proven.

Latest analyst questions

Analyzed call: Q3 2026 — 2026-10-29 · Research snapshot: 2026-11-05

Latest call: Q3 2026, October 29. Complete material analyst exchanges are presented below in original paraphrase, including the questions, substantive responses and independent investment implications. They replace the Q2 Q&A as the current quarter; preceding-quarter questions remain in historical source context.

Analyst / Firm Core Question Management Response Research Read-Through
Patrick Moley / Piper Sandler How much of the Q3 options RPC decline came from ORF, July fees (including the partial August reversal), or trading mix, and should investors expect a rebound from $0.098? CFO Emmons attributed roughly $0.006 of the Q1-to-Q3 drop to regulatory fees and about $0.008–0.009 to fee changes, offset by ~$0.003 favorable mix, subject to rounding and variation. With no additional October/November fee changes then planned, approximately $0.10 was a sensible reference, not a promise. Lower normalized capture makes the base case less certain.
Patrick Moley / Piper Sandler — follow-up Why has full-year expense guidance repeatedly come down, and how much headcount, technology and Bloomberg-related marketing expenditure will return in 2027? Lower summer marketing reflected launch timing. Management expects higher Q4/2027 customer and Bloomberg promotions, selective hiring and technology maintenance inflation, partly offset by early hardware purchases. Detailed 2027 plans await Q4 reporting. Do not project permanently flat expenses from Q3 alone.
Jeff Schmitt / William Blair How large are the financial futures launch subsidies, marketing and quoting costs, and when should incentives decline? Financial-futures capture was roughly negative $1.42 per contract because of waivers/rebates. Management hopes for eventual positive $0.25–$0.30 capture depending on product, with ~$0.5–$1M quarterly quoting incentives plus marketing while liquidity builds; no break-even timetable guaranteed. Keep futures losses in bear and base; avoid premature profit credit.
Jeff Schmitt / William Blair — follow-up With NinjaTrader live, how quickly can distribution widen, and what remains to be done before brokers can bring active customers? One firm was live, another had finished testing and was expected soon, and two others were progressing through connection/testing. Joint retail/professional marketing should follow these integrations. Technical connections do not yet prove trade volume and profitability.
Ken Worthington / JPMorgan Why did options price capture decline so sharply for only modest year-over-year share gains? Is competition or product/customer mix more important? Management described share and pricing as related but not mechanically inverse: auctions, customer mix, member tiers and market conditions influence capture, alongside deliberate fee changes. It remained comfortable with revenue optimization. The weak capture/share trade-off is the principal bearish sensitivity.
Ken Worthington / JPMorgan — follow-up Does approximately $0.10 capture imply new market share gains, or is it roughly appropriate for current share? Management would not attach a numerical share forecast to RPC. Complex-order and Sapphire floor functionality can gain activity at favorable economics; individual customer opportunities matter more than one fee point. Model share and capture as distinct drivers.
Ken Worthington / JPMorgan — follow-up Has MIAX's technical advantage matured, or can its latency, throughput and risk protections continue helping market makers and driving share growth? CEO Gallagher and CIO Schafer pointed to deterministic low latency, high throughput and evolving risk controls, plus new exchange-floor capabilities. These are management assertions about the ability to compete in volatile markets. Maintains the core moat assessment, pending evidence from sustained economic share.
Chris Brendler / Rosenblatt Are new exchanges materially changing the competitive landscape, or is Q3's unusual pricing/share mix mostly MIAX-specific? Management viewed new entrants as technologically and functionally less developed and highlighted additional electronic and floor product functionality as the next share drivers. Do not assume new rivals cannot eventually compete on fees.
Chris Brendler / Rosenblatt — follow-up Why consider perpetual futures or other emerging market structures when MIAX's appeal is focus and discipline? Management emphasized three conditions before committing: verified customer demand, a workable regulatory route, and economics that justify development. Shared technology could reduce incremental rollout costs. Encouraging stated discipline; do not capitalize unapproved products.

Analyst-Q&A Takeaway

Compared with Q2, the market's key challenge has moved from unexpectedly high RPC to actual Q3 fee/capture deterioration, while management provided specific cost estimates for financial-futures incentives and warned that marketing/headcount spend can rebound. Those points support a more cautious probability weighting even as Q3 margins improved.

Sources and research notes
Source Type Date / Period What It Supports
MIAX Q3 2026 earnings release Company IR Q3 2026 Financial results, segment results, share, volume, guidance, cash and debt
MIAX Q3 2026 Form 10-Q SEC filing 2026-09-30 Nine-month cash flow, SBC, share counts, nonrecurring GAAP items, capitalization
MIAX Q2 2026 Form 10-Q SEC filing 2026-06-30 Six-month cash-flow statement, capital spending, software capitalization, and SBC supporting derived Q3 FCF
MIAX Q3 2026 earnings call Q&A transcript via Quartr 2026-10-29 Analyst questions, RPC bridge, future subsidies, technology/competition
MIAX binary index and KPI options announcement Company IR 2026-11-03 Proposed products, SEC-review dependency and timing
MIAX historical prices Market-data reference 2026-11-04 $34.97 regular-session close
MIAX statistics — StockAnalysis/S&P Market-data research reference 2026-11-04 Capitalization and multiples cross-check
Cboe statistics — StockAnalysis/S&P Comparable research reference 2026-11-04 Exchange multiple cross-check
ICE statistics — StockAnalysis/S&P Comparable research reference 2026-11-04 Exchange multiple cross-check
Nasdaq statistics — StockAnalysis/S&P Comparable research reference 2026-11-04 Exchange multiple cross-check
CME statistics — StockAnalysis/S&P Comparable research reference 2026-11-04 Futures network/multiple cross-check
MIAX Q2 2026 earnings release Company IR Q2 / H1 2026 Prior operating baseline
MIAX Q2 2026 earnings-call transcript Historical Q&A 2026-08-05 Preceding analyst debates
MIAX September trading statistics Company IR September 2026 Earlier YTD share and ADV
MIAX 2025 Form 10-K SEC filing FY2025 Annual business and historical results
MIAX Dorman OCC membership Company IR 2026-09-24 FCM distribution/clearing infrastructure
SEC XBRL company facts — MIAX Regulatory filing (as tagged) FY2026, through 2026-09-30 Current-year standalone-quarter and year-to-date source facts for FCF, SBC, revenue and other reported metrics

Third-party market-data figures are dated research verification references, not licensed public redistribution feeds. Model estimates and scenario probabilities are independent research.

Research context

  • Company: Miami International Holdings
  • Ticker: MIAX
  • Exchange: NYSE
  • Sector / Industry: Financial Exchanges & Market Data
  • Template version: 2.7
  • Research date: 2026-11-05
  • Valuation / score price snapshot: $34.97 — 2026-11-04 regular-session close (America/New_York; dated research reference)
  • Valuation refresh date: 2026-11-05
  • Tracking tier: Primary Watchlist
  • Owned: No
  • Primary operating period reviewed: Q3 / nine months 2026
  • Historical period reviewed: FY2024–FY2025, H1 2026 and Q3 2025 comparative
  • Latest investor presentation reviewed: Q3 2026 earnings materials and call slides
  • Latest earnings call reviewed: Q3 2026 — 2026-10-29
  • Latest post-earnings management commentary reviewed: 2026-11-03 proposal for binary index and KPI options

This is a substantive earnings and valuation review, not a daily price update. Historical October/early-November research and price-only snapshots remain in Investment Decision History. FolioFacts owns live prices, Opportunity Scores, rankings and live trading zones.

Full original report

MIAX — Miami International Holdings

Company & Research Metadata

  • Company: Miami International Holdings
  • Ticker: MIAX
  • Exchange: NYSE
  • Sector / Industry: Financial Exchanges & Market Data
  • Template version: 2.7
  • Research date: 2026-11-05
  • Valuation / score price snapshot: $34.97 — 2026-11-04 regular-session close (America/New_York; dated research reference)
  • Valuation refresh date: 2026-11-05
  • Tracking tier: Primary Watchlist
  • Owned: No
  • Primary operating period reviewed: Q3 / nine months 2026
  • Historical period reviewed: FY2024–FY2025, H1 2026 and Q3 2025 comparative
  • Latest investor presentation reviewed: Q3 2026 earnings materials and call slides
  • Latest earnings call reviewed: Q3 2026 — 2026-10-29
  • Latest post-earnings management commentary reviewed: 2026-11-03 proposal for binary index and KPI options

This is a substantive earnings and valuation review, not a daily price update. Historical October/early-November research and price-only snapshots remain in Investment Decision History. FolioFacts owns live prices, Opportunity Scores, rankings and live trading zones.

What's Changed Since Previous Review

Current Review: 2026-11-05
Previous Review: 2026-10-28 competitor/Q&A correction (previous fundamental valuation dated 2026-10-06; November 3 price-only snapshot)
Update Trigger: Q3 earnings, subsequent 10-Q, earnings call, Nov. 3 product announcement and valuation reassessment

Area Previous View Current View Investment Impact
Core options Q2 $124.4M net revenue and unusually high $0.124 RPC Q3 $112.6M net revenue, 17.4% market share and $0.098 RPC Earnings still healthy, but ~$0.10 is now better pricing baseline
Profitability Strong H1 expansion Q3 adj. EBITDA $70.8M, +47.5% YoY, 54.0% margin; adjusted OpEx -2% Stronger evidence of operating leverage
Per-share economics Q2 adjusted earnings +41%, EPS flat Q3 adjusted earnings +25%, diluted EPS +7% Dilution remains central
Cash and investment ~$660M cash at Q2 end, futures startup $698.9M cash and $1.5M debt; futures Q3 EBITDA loss $8.4M Balance-sheet resilience with capital deployment risk
New products Bloomberg futures launch NinjaTrader distribution; Nov. 3 binary-options applications filed Product option value, not proven earnings
Fundamental valuation $22.50 / $39 / $53, weights 25/55/20, weighted $37.68 $21 / $38 / $53, weights 30/50/20, weighted $35.90 4.7% downgrade reflecting pricing uncertainty
Scores Quality 78.9; valuation confidence 58 Quality 78.9 retained; confidence 55 Core quality intact, slightly weaker forecast confidence

Thesis: Unchanged; risk/reward weakened. The operating franchise has improved, but the observed capture decline and continued diluted-share growth justify more conservative scenario weights. Price movement from the older $33.86 closing reference is separate from the 4.7% decline in fundamental weighted fair value.

Investment Snapshot

Metric Current View
Price Snapshot $34.97 — 2026-11-04 regular-session close
Bear / Base / Bull Fair Value $21 / $38 / $53
Scenario Probabilities 30% / 50% / 20%
Probability-Weighted Fair Value $35.90
Return at Dated Reference Price +2.7% probability-weighted; -40.0% bear case
Quality Score / Tier 78.9 / Tier B
Risk Level Medium-High
Valuation Confidence 55/100
Tracking / Ownership Primary Watchlist / Not Owned

Decision rationale: Excellent core options economics and liquidity do not offset a narrow weighted valuation cushion at the dated $34.97 price. Live Opportunity Score, ranking, rating/zone and trading bands belong to FolioFacts, not this fundamental file.

Investment Thesis

MIAX has become a scaled U.S. options venue group. Its 17.4% Q3 2026 options share and 76.8% options segment adjusted EBITDA margin provide evidence of a viable exchange technology and liquidity franchise against Cboe, Nasdaq and NYSE options venues. The business can compound earnings if growing industry volumes, connectivity and data revenue translate into superior per-share economics.

The difficult question is not whether MIAX can process volume efficiently; it is whether it can retain flow without cutting revenue per contract too much, and whether diluted EPS can compound after SBC, warrants and other share issuance. Q3 revenue per contract of $0.098, versus Q2's exceptional $0.124, illustrates the risk. Futures, international exchanges and new proprietary contracts are option value, not currently the foundation of earnings.

What the Market May Be Mispricing

Debate Current Assessment
Is MIAX still a marginal options exchange? No: 17.4% U.S. options share and substantial core profitability establish meaningful scale
Is Q2 revenue per options contract the new normal? No: Q3 $0.098 and management's ~$0.10 reset are better near-term anchors
Does adjusted EBITDA growth translate to EPS? Not fully: Q3 adjusted EBITDA +47.5% vs adjusted EPS +7%
Should MIAX cash be added on top of a P/E valuation? No: a whole-equity earnings multiple already includes cash value
Should futures/new proprietary products command a high premium? Only after volume, positive capture and regulatory/operating outcomes are demonstrated

Business Overview

MIAX operates multiple regulated venues using proprietary exchange infrastructure. Transaction fees, exchange connectivity, market data and listings support its revenues; net revenue after liquidity payments and other transaction costs, not gross fees, better captures the operating economics.

Segment / Platform Role Q3 Net Revenue Q3 Adjusted EBITDA Assessment
Options — MIAX Options/Pearl/Emerald/Sapphire U.S. multi-listed options $112.6M (+19% YoY) $86.5M Main profit pool, 76.8% EBITDA margin
Equities — Pearl Equities U.S. cash equities $6.7M (+53% YoY) $1.0M Small but improving
Futures / Bloomberg / agricultural Futures marketplace/products $5.0M (+4% YoY) -$8.4M Early-stage investment and incentives
International — BSX / TISE Listings and market infrastructure $6.1M (+11% YoY) $2.3M Small profitable diversification
Corporate/other Consolidating activity $0.6M — Not a separate growth engine

Options accounted for roughly 86% of Q3 net revenue. Dorman Trading's additional FCM capital and OCC clearing membership support broker access to MIAX futures; neither proves customer adoption or sustainable positive pricing.

On November 3, MIAX announced filings proposing binary Bloomberg-index options, with a potential 2027 introduction subject to SEC review, and company-KPI binary options without a firm launch date. No unapproved product revenue is assumed in the base model.

Business Takeaway

The core options franchise already finances the company. The adjacent businesses offer diversification but still require validated demand, liquidity and economic returns.

Industry, TAM & Market Share

Options industry growth remains supportive. MIAX's Q3 options average daily volume reached approximately 11.1 million contracts, up 15.2% YoY, and market share increased to 17.4% versus 17.2% a year earlier and 16.5% sequentially in Q2. The sequential rebound is useful; the small YoY share gain means industry trading growth, rather than a dramatic competitive shift, still explains much of the improvement.

Market-Share Analysis

Direct competitors span multiple U.S. options venues; consistent, current market-share figures for all venues were not available, so relative competitive positions are compared below rather than asserting incompatible market-share estimates.

Company / Platform Primary Position Relative Scale Growth Direction Investment Relevance
MIAX U.S. listed options, with developing equity and futures venues 17.4% Q3 2026 U.S. options share Modest YoY share gain Core options economics drive valuation; futures remain an investment
Cboe Direct U.S. listed-options competitor Broader product and proprietary-IP ecosystem Strong Primary direct exchange competitor
Nasdaq U.S. listed options and equities More diversified group Stable Direct options competitor and secondary valuation anchor
NYSE / ICE U.S. options and equities venues; ICE also operates futures Broad, diversified parent Strong Direct U.S. options competitor, diversified valuation anchor
BOX / MEMX Overlapping U.S. exchange venues Smaller competitors in the MIAX analysis Mixed Fee competition affects capture
CME Futures market Entrenched futures liquidity network Strong Futures benchmark, not a listed-options share comparator

MIAX reported share observations across different periods and products (preserved from the earnings review):

Product / Definition Current Period Prior Period Interpretation
MIAX U.S. listed-options share, Q3 2026 17.4% 17.2% Q3 2025 Share improvement, but modest
MIAX U.S. listed-options share, Q3 vs Q2 2026 17.4% 16.5% Q2 2026 Sequential recovery
MIAX U.S. equities market share, earlier YTD 2026 ~0.8% ~1.1% prior-year period Weak adjacency

A consistently defined, current U.S.-listed-options share table across Cboe, Nasdaq, NYSE, BOX and MEMX was not available from the source set used, so no incompatible peer figures are implied. Direct competitors are separated from futures-only competitors in the following section.

Industry Takeaway

The options franchise has genuine relevance and a sizable transaction market. Volume growth without retained per-contract capture, however, cannot guarantee earnings growth.

Customer Economics

MIAX core transaction economics can be expressed as industry options volume × MIAX market share × net revenue per contract, plus access, connectivity, market data and other fees.

Q3 options revenue per contract (RPC) fell to $0.098, from $0.124 Q2 and $0.110 Q1. Management indicated that the Q1-to-Q3 decline reflected roughly $0.006 of Options Regulatory Fee impact, approximately $0.008–0.009 of fee changes during July (partially reversed in August), and around +$0.003 of favorable mix. Those rounded drivers were explicitly uncertain. Management offered roughly $0.10 as a practical near-term reset, not a fixed floor or guarantee.

Non-transaction options fees grew 38% YoY as connections, January 2026 pricing and historical data sales expanded. About $2M of Q3 historical data sales can vary; management plans approximately 10% higher access fees from January 2027. This reduces reliance on pure trading capture but does not turn the exchange into a locked-in subscription model.

Financial futures transaction capture was approximately -$1.42 per contract under launch waivers/rebates. Quoting subsidies are roughly $0.5–$1M per quarter, plus marketing. Management expects capture to improve as retail adoption increases but gave no firm break-even commitment.

Customer-Economics Takeaway

Attractive exchange incremental margins coexist with low contractual switching costs. Share gains at falling RPC can be uneconomic; monitor both together and avoid treating futures incentivized volume as profitable growth.

Competitive Landscape & Moat

Competitive Landscape

Competitor Market Share Positioning Advantages vs. Company Disadvantages vs. Company Current Direction
Cboe N/A on a directly comparable single-group basis in this analysis Direct segments: U.S. listed options and overlapping derivatives Broader product/IP ecosystem and global scale MIAX can be more agile and focused Strong
Nasdaq N/A on a directly comparable single-group basis in this analysis Direct segments: U.S. options and equities exchanges Substantially more diversified MIAX has strong purpose-built options architecture Stable
NYSE / ICE N/A on a directly comparable single-group basis in this analysis Direct segments: U.S. options/equities venues; parent futures not equivalent Dominant data, futures and clearing assets MIAX has gained meaningful options share despite smaller scale Strong
CME N/A — futures market differs Direct segment: competing futures contracts; not an options-share comparator Extraordinary futures liquidity/network effects Bloomberg partnership gives MIAX differentiated products Strong
BOX / MEMX N/A Direct: overlapping U.S. exchange venues Fee competition remains intense MIAX has greater options scale Mixed

Moat Assessment

MIAX's most credible moat is its purpose-built exchange technology and the liquidity ecosystem accumulated around it. Management argues that its low-latency architecture, deterministic performance and risk controls allow market makers to quote more aggressively. Exchange rules can often be copied; the full technological implementation and liquidity network are harder to replicate.

Regulatory licenses and member connectivity are additional barriers, but not absolute ones. Sophisticated trading firms multi-home across venues and move flow based on economics.

Moat direction: Stable to modestly strengthening.

Competitive Takeaway

MIAX has built a real competitive position in options, but I would not characterize it as having the same network-effect depth as CME's futures complex or the breadth of ICE, Cboe or Nasdaq. The moat is good enough to support attractive economics, not good enough to eliminate price competition.

Financial Profile

Q3 consolidated net revenue was $131.0M (+19.7% YoY) and adjusted EBITDA $70.8M (+47.5%), lifting adjusted margin to 54.0% from roughly 44%. Adjusted operating expense declined approximately 2% to $60.3M. This is strong operating leverage; the GAAP period comparison includes unusual IPO-period costs and other discrete adjustments.

Historical Financials

Financial reporting periods follow the issuer's fiscal year: completed FY rows plus standalone current-year quarters and cumulative H1/9M for FY2026. Revenue is issuer net revenue (revenues less cost of revenues), not the gross US-GAAP revenues tagged in SEC company facts. FCF is operating cash flow minus both purchases of property/equipment and capitalized internal software. Q3 FCF is derived by subtracting H1 from 9M. Q1 and Q2 standalone FCF remain N/D pending source-verified matching quarterly cash outflows. SBC is the same-period issuer-disclosed amount; cash is a period-end balance. Missing values are N/D, not zero. Unit: USD millions. Data extracted from SEC-tagged filings as of 2026-11-07. Company-specific FCF definitions and acquisition effects may require further reconciliation.

Period Revenue Growth Gross Margin Operating Margin FCF FCF Margin SBC Diluted Shares Cash Debt
FY2024 $275.6M +18.6% N/D N/D FCF ~$84.7M (earlier provider definition) N/D $43.6M ~74.6M adjusted N/D N/D
FY2025 $430.5M +56.2% N/D N/D FCF ~$145M (earlier provider definition) N/D $57.6M ~90.6M adjusted N/D N/D
Q1 FY2026 $128.593M (derived: H1 less Q2 net revenue) N/D N/D N/D N/D N/D $8.673M 109.154M $550.786M N/D
Q2 FY2026 $141.113M +34.8% N/D 19.7% N/D N/D $7.290M 110.714M $660.462M N/D
H1 FY2026 $269.706M +37.2% N/D N/D $150.564M (derived: CFO less PPE capex and capitalized software) 55.8% $15.963M 109.944M $660.462M N/D
Q3 FY2026 $131.009M +19.7% N/D 36.0% $18.760M (derived: 9M less H1 FCF) 14.3% $7.539M 110.799M $698.854M ~$1.5M
9M FY2026 $400.715M +30.9% N/D N/D $169.324M (derived: CFO less PPE capex and capitalized software) 42.3% $23.502M 110.249M $698.854M ~$1.5M

Supplemental historical reporting context (retained)

Supplemental earnings-release presentation, preserving adjusted EBITDA/margin and original cash-flow classifications:

Period Net Revenue Growth Adjusted EBITDA / Margin Cash Flow SBC Diluted Shares Cash / Debt
FY2024 $275.6M +18.6% Historical FCF ~$84.7M (earlier provider definition) $43.6M ~74.6M adjusted Historical
FY2025 $430.5M +56.2% $199.1M / 46.2% FCF ~$145M (earlier provider definition) $57.6M ~90.6M adjusted Historical
H1 2026 $269.7M +37.2% ~$142.9M / ~53% $150.564M FCF (calculated, includes software capex) $15.963M Q2 adj. diluted ~110.7M ~$660M / ~$1.5M
Q3 2026 $131.0M +19.7% $70.8M / 54.0% $18.760M FCF (derived from 9M less H1 cash flows) $7.539M 110.8M adjusted $698.9M / $1.5M
9M 2026 $400.7M +30.9% ~$213.7M / ~53.3% $206.708M OCF / $169.324M FCF including software capex $23.502M ~110.2M GAAP diluted $698.9M / $1.5M

SBC disclosure: Q3 2026 share-based compensation was $7.539M, versus $29.098M in Q3 2025; nine-month 2026 SBC was $23.502M, versus $48.007M in 9M 2025. The prior-year quarter included accelerated equity compensation related to the IPO. Amounts are from MIAX's Q3 2026 earnings reconciliation and 10-Q; these costs remain economically relevant even when excluded from adjusted results.

2026 cash-flow reconciliation ($M): The company publishes cumulative cash-flow statements; the Q3 cash-flow entries below are calculated as 9M less H1, not separately reported quarterly cash-flow line items. FCF consistently subtracts both property/equipment capital expenditures and capitalized internal software from operating cash flow. SBC is separately reported for Q3.

Cash-flow item H1 2026 (6M) 9M 2026 (9M) Q3 2026 (9M minus H1)
Operating cash flow $183.642M $206.708M $23.066M
Capital expenditures $27.992M $29.438M $1.446M
Capitalized internal software $5.086M $7.946M $2.860M
Free cash flow (calculated) $150.564M $169.324M $18.760M
Stock-based compensation $15.963M $23.502M $7.539M (reported Q3)

Time-period warning: H1 and 9M are overlapping cumulative periods; Q3 is a three-month standalone period. Do not compare Q3's dollar bars directly with full-year or year-to-date totals. FY2024–FY2025 FCF values retain an earlier provider definition and should not be assumed comparable with this 2026 capex-inclusive definition.

Nine-month free cash flow shown here deducts $29.438M capital spending and $7.946M capitalized internal software from $206.708M operating cash flow, yielding $169.324M (~42.3% net revenue margin). Previous annual FCF figures use a different provider convention and should not be treated as identical definitions.

Q3 adjusted earnings $50.1M (+25%) turned into adjusted EPS $0.45 (+7%), because adjusted diluted shares increased from 96.1M to 110.8M (~15%). The large historical basic-share increase is partly capital-structure/IPO/warrant conversion related, not all continuing employee compensation. Nevertheless, SBC and future diluted share growth matter. GAAP 9M profits are inflated by a tax valuation allowance reversal and MIAXdx sale gain, while a $30M litigation settlement is a large discrete charge; avoid valuing the stock using unnormalized GAAP profits.

Financial Takeaways

MIAX converts scale into margins and cash, has very little funded debt, and can afford to invest. Future per-share value creation still depends on stabilizing RPC, minimizing dilution and earning satisfactory returns on futures capital.

Financial direction: Improving operations, mixed per-share value creation.

Management & Capital Allocation

Management deserves credit for scaling its options venues and reducing FY2026 adjusted operating expense guidance to $254–257M from $260–270M, while Q3 revenue and margin advanced. However, planned marketing, quoting support, hiring and technology costs are expected to rebound in Q4 and into 2027; Q3 should not be treated as a permanent zero-growth expense base.

Updated FY2026 guidance also calls for $30–32M SBC, $43–46M capex (including software capitalization), and a 26–28% adjusted tax rate. Dorman received a $40M capital increase to support greater futures activity and clearing. Management favors reinvestment and selective deals over near-term distributions; large cash balances must therefore be evaluated alongside potential product-launch returns and dilution.

The post-quarter binary-option plans and commentary about perpetuals are opportunities, not approved profit streams. Management described customer demand, regulatory clarity and economic returns as necessary decision gates before committing to new products.

Management Takeaway

Above-average operating execution, but new-market capital allocation and consistent per-share growth have yet to be proven.

Valuation

Current Valuation

Re-underwritten November 5, 2026.

Metric Value
Price Snapshot $34.97, Nov. 4 regular-session close
Shares outstanding (basic, approx.) 100.06M
Market Capitalization ~$3.50B ($34.97 × 100.06M)
Cash / funded debt, Sept. 30 $698.9M / $1.5M
Enterprise Value ~$2.80B, simplified equity less cash plus funded debt (not a fully adjusted EV)
Annualized Q3 adjusted EBITDA ~$283.2M
EV / Q3 annualized adjusted EBITDA ~9.9×
Annualized 9M adjusted EPS ~$1.80 (illustrative, not company guidance)
Price / annualized 9M adjusted EPS ~19.4×
Annualized 9M FCF after software capex ~$225.8M, ~15.5× price/FCF

The annualized figures are not forward guidance and differ from vendor TTM and conventional GAAP metrics. Cash excludes restricted/customer-clearing cash and the simple EV bridge excludes possible debt/lease/investment adjustments. P/E scenario fair values value the entire equity including cash; do not add net cash again.

Comparable Company Analysis

November 4 same-provider research cross-check, with differing business mix and source definitions. MIAX's internally calculated annualized and adjusted metrics are not strictly equivalent to the following vendor-reported metrics.

Company Relevance Public / Private Forward P/E Price / FCF EV / EBITDA Growth / Margin / Risk Context
MIAX Core exchange subject; annualized adjusted research metrics Public ~19.4× EPS run-rate ~15.5× annualized 9M FCF ~9.9× Q3 annualized adjusted EBITDA Strong core options margins and liquidity; RPC and dilution remain material risks
Cboe Direct listed-options peer Public 22.8× 14.2× 17.2× Direct options competitor; broader product and intellectual-property base
ICE Listed-exchange segment competitor and diversified valuation anchor Public 20.4× 18.5× 17.3× Diversified exchange group; listed-options segment is only one activity
Nasdaq U.S. options/equities competitor and diversified anchor Public 24.0× 27.0× 20.0× Diversified options/equities venue and technology group
CME Futures-only network-effects benchmark Public 23.8× 25.5× 22.6× Futures-network valuation benchmark, not a listed-options share peer

These larger operators generally deserve higher multiples for proprietary products, liquidity networks and/or diversification. Do not force their multiple average on MIAX.

Valuation Scenarios

Normalized 2027 adjusted diluted EPS scenarios.

Scenario Key Assumptions 2027 EPS Multiple Fair Value Probability Probability Rationale Return From Price Snapshot
Bear Share drifts toward 15–16%, RPC <$0.095, industry volumes weaken, futures losses persist and dilution continues $1.50 14× $21.00 30% RPC pressure, futures losses and dilution justify raising the bear weight to 30% -40.0%
Base Options share ~17%, RPC near ~$0.10, access/data fees grow, operating leverage offsets only gradually improving futures losses and moderate dilution $2.00 19× $38.00 50% Q3 margins support normalized earnings if RPC and diluted shares stabilize +8.7%
Bull Rising profitable options volumes, successful services and real futures retail adoption at improving net capture; dilution moderates ~$2.30 ~23× $53.00 20% Successful product economics are unproven; weight remains limited to 20% +51.6%
Probability-Weighted 30% Bear / 50% Base / 20% Bull $35.90 100% Weighted average of the three scenarios +2.7%

Arithmetic: 0.30 × $21 + 0.50 × $38 + 0.20 × $53 = $35.90.

Changes from the preceding underwriting: Bear falls $22.50 → $21 because lower RPC and sustained dilution increase downside earnings/multiple sensitivity. Base $39 → $38 because $2.00 normalized EPS is retained but its multiple is cut 19.5× → 19×. The EPS is retained deliberately after Q3: improved operating margins and lower expense guidance still support earnings growth from the annualized ~$1.80 nine-month adjusted EPS baseline, provided capture stabilizes and dilution slows. Bull $53 remains unchanged: ~$2.30 EPS and stronger proprietary-product economics are plausible but unproven, so its weight stays 20%. Bear weight rises 25% → 30%; base weight falls 55% → 50%.

The prior P/W value $37.68 is therefore cut to $35.90 (-4.7%). At today's dated research reference close, the old $37.68 value would imply ~7.7% upside, whereas the new valuation implies ~2.7%. That separates the effect of a higher stock price from the fundamental model downgrade.

Valuation Takeaway

  • Primary valuation method: Scenario P/E multiples applied to normalized 2027 adjusted diluted EPS.
  • Valuation refresh date / changes vs. previous valuation (including reasons for unchanged inputs): 2026-11-05; bear $22.50 → $21, base $39 → $38, bull retained at $53, and probability-weighted fair value $37.68 → $35.90, as explained above.
  • Cross-check methods: Annualized Q3 adjusted EBITDA and EV/EBITDA, annualized nine-month adjusted EPS and P/E, annualized nine-month FCF and price/FCF, and exchange peers.
  • Key valuation dependencies: Options market share, ~$0.10 per-contract capture, diluted-share growth, futures losses and returns on new products.
  • Valuation confidence / Risk Level: 55/100 / Medium-High.
  • Margin-of-safety conclusion: At the November 4 reference close of $34.97, $35.90 weighted fair value provides only ~2.7% modeled upside against ~40% bear-case downside.

Quality 78.9 / Tier B unchanged. Valuation confidence 55/100, down from 58, with Medium-High risk. MIAX has a valuable options franchise, but at $34.97 there is little modeled weighted upside and significant downside under a pricing and dilution stress. This report sets no live Buy/Hold zones, rankings or Opportunity Score; FolioFacts owns those functions.

Analyst Questions

Latest call: Q3 2026, October 29. Complete material analyst exchanges are presented below in original paraphrase, including the questions, substantive responses and independent investment implications. They replace the Q2 Q&A as the current quarter; preceding-quarter questions remain in historical source context.

Analyst / Firm Core Question Management Response Research Read-Through
Patrick Moley / Piper Sandler How much of the Q3 options RPC decline came from ORF, July fees (including the partial August reversal), or trading mix, and should investors expect a rebound from $0.098? CFO Emmons attributed roughly $0.006 of the Q1-to-Q3 drop to regulatory fees and about $0.008–0.009 to fee changes, offset by ~$0.003 favorable mix, subject to rounding and variation. With no additional October/November fee changes then planned, approximately $0.10 was a sensible reference, not a promise. Lower normalized capture makes the base case less certain.
Patrick Moley / Piper Sandler — follow-up Why has full-year expense guidance repeatedly come down, and how much headcount, technology and Bloomberg-related marketing expenditure will return in 2027? Lower summer marketing reflected launch timing. Management expects higher Q4/2027 customer and Bloomberg promotions, selective hiring and technology maintenance inflation, partly offset by early hardware purchases. Detailed 2027 plans await Q4 reporting. Do not project permanently flat expenses from Q3 alone.
Jeff Schmitt / William Blair How large are the financial futures launch subsidies, marketing and quoting costs, and when should incentives decline? Financial-futures capture was roughly negative $1.42 per contract because of waivers/rebates. Management hopes for eventual positive $0.25–$0.30 capture depending on product, with ~$0.5–$1M quarterly quoting incentives plus marketing while liquidity builds; no break-even timetable guaranteed. Keep futures losses in bear and base; avoid premature profit credit.
Jeff Schmitt / William Blair — follow-up With NinjaTrader live, how quickly can distribution widen, and what remains to be done before brokers can bring active customers? One firm was live, another had finished testing and was expected soon, and two others were progressing through connection/testing. Joint retail/professional marketing should follow these integrations. Technical connections do not yet prove trade volume and profitability.
Ken Worthington / JPMorgan Why did options price capture decline so sharply for only modest year-over-year share gains? Is competition or product/customer mix more important? Management described share and pricing as related but not mechanically inverse: auctions, customer mix, member tiers and market conditions influence capture, alongside deliberate fee changes. It remained comfortable with revenue optimization. The weak capture/share trade-off is the principal bearish sensitivity.
Ken Worthington / JPMorgan — follow-up Does approximately $0.10 capture imply new market share gains, or is it roughly appropriate for current share? Management would not attach a numerical share forecast to RPC. Complex-order and Sapphire floor functionality can gain activity at favorable economics; individual customer opportunities matter more than one fee point. Model share and capture as distinct drivers.
Ken Worthington / JPMorgan — follow-up Has MIAX's technical advantage matured, or can its latency, throughput and risk protections continue helping market makers and driving share growth? CEO Gallagher and CIO Schafer pointed to deterministic low latency, high throughput and evolving risk controls, plus new exchange-floor capabilities. These are management assertions about the ability to compete in volatile markets. Maintains the core moat assessment, pending evidence from sustained economic share.
Chris Brendler / Rosenblatt Are new exchanges materially changing the competitive landscape, or is Q3's unusual pricing/share mix mostly MIAX-specific? Management viewed new entrants as technologically and functionally less developed and highlighted additional electronic and floor product functionality as the next share drivers. Do not assume new rivals cannot eventually compete on fees.
Chris Brendler / Rosenblatt — follow-up Why consider perpetual futures or other emerging market structures when MIAX's appeal is focus and discipline? Management emphasized three conditions before committing: verified customer demand, a workable regulatory route, and economics that justify development. Shared technology could reduce incremental rollout costs. Encouraging stated discipline; do not capitalize unapproved products.

Analyst-Q&A Takeaway

Compared with Q2, the market's key challenge has moved from unexpectedly high RPC to actual Q3 fee/capture deterioration, while management provided specific cost estimates for financial-futures incentives and warned that marketing/headcount spend can rebound. Those points support a more cautious probability weighting even as Q3 margins improved.

Thesis Monitoring

Driver Current State Positive Trigger / Catalyst Negative Trigger / Falsifier What It Changes
Options share 17.4% Q3 Sustained ≥17% with good capture Toward 15–16% Moat / EPS
Options RPC $0.098 Q3; ~$0.10 indicated reset Stable ≥$0.10 Persistent <$0.095 Highest-priority valuation sensitivity
Options ADV ~11.1M, +15.2% YoY Durable industry growth Multi-quarter downturn Revenue growth
Access/data revenue +38% YoY; ~$2M variable historical-data sales Member expansion, Jan. 2027 fee increase sticks One-time or customer pushback Revenue mix
Dilution/SBC 110.8M Q3 adj. diluted shares vs 96.1M EPS growth catches earnings growth Continued double-digit dilution Per-share compounding
Futures -$8.4M Q3 adj. EBITDA; initial negative capture Multiple brokers drive real volume and positive economics Continuing high subsidies without users Optionality
Proposed binary products Nov. 3 SEC filings Regulatory approval and monetization Delayed approval, weak demand Optionality, not base EPS
Cash/investment discipline ~$699M cash, Dorman funded, ~$1.5M debt Product returns and prudent spending Overinvestment/acquisitions Valuation confidence
Competitors Cboe/NYSE/Nasdaq in listed options; CME in futures Product-led capture gains Aggressive fee pressure Moat and margins

Quality & Opportunity Scorecards

Quality Score

Component Score Weight Weighted Contribution Evidence
Business durability and economics 80 25% 20.0 High incremental margins and strong core exchange economics, offset by transaction dependence
Moat and competitive position 78 25% 19.5 Meaningful options scale, technology and licenses, but multi-homing and price competition limit switching costs
Growth runway and durability 83 20% 16.6 Options share gains plus futures/international optionality
Financial quality and balance sheet 80 15% 12.0 Excellent liquidity and FCF, materially offset by SBC/dilution
Management, governance and capital allocation 72 15% 10.8 Strong operating execution; per-share capital allocation remains less proven
Quality Score 78.9 100% 78.9 Tier B
  • Quality Tier: B
  • Speculative override: None

MIAX narrowly misses Tier A. The business itself is approaching A-level economics, but I do not think a company with this degree of dilution, options concentration and unproven capital deployment into futures deserves an 80+ Quality Score yet.

Opportunity Score — Historical Context Only

The former 61.1 Opportunity Score / historical rank was generated from the November 3 price-only snapshot and is preserved below in Investment Decision History, not recalculated here. FolioFacts solely calculates live price-dependent scores, rankings and zones from company fundamentals.

Portfolio Context

  • Tracking tier: Primary Watchlist
  • Owned: No
  • Tracking source of truth: my_watchlist.md
  • Portfolio source of truth: portfolio/holdings.md
  • Scoring independence: Ownership, account, share count, position size, and cost basis do not alter Quality Score, Opportunity Score, rank, rating, valuation, or valuation zones.

Investment Decision History

Timestamp Price Rating Zone Status Buy Zone Strong Buy Zone Avoid Chasing Above Base FV P/W FV P/W Return Quality Opportunity / Rank Change / Rationale
2026-10-06 $30.79 Buy Buy $25–$32.50 ≤ $25 > $44 $39.00 $37.68 +22.4% 78.9 70.1 / Pending Initial analysis
2026-10-21 (America/New_York) $32.41 Buy Buy >$25.00–$32.50 ≤ $25.00 > $44.00 $39.00 $37.68 +16.3% 78.9 65.1 / #12 Common close and shared-universe rank; prior fundamental assumptions and zones preserved
2026-11-05 fundamental Q3 review (11/04 reference close) $34.97 Research: limited safety margin — FolioFacts — — — $38.00 $35.90 +2.7% dated 78.9 — FolioFacts Reassessed bear/base/bull $21/$38/$53; weights 30/50/20; valuation confidence 55; documented stronger margins, lower RPC and dilution; prior decisions preserved

Final Investment View

MIAX's core options franchise is attractive, but at the November 4 reference price of $34.97 the new $35.90 probability-weighted value implies only ~2.7% upside. It is no longer a sufficiently wide modeled margin of safety for an aggressive fundamental Buy call. The 76.8% option segment adjusted EBITDA margin, strong cash generation and liquidity support the thesis; the pricing, dilution, futures subsidies and product-regulatory uncertainties explain the cautious multiple and scenarios.

The historical October 2026 Buy call remains above in the decision record. Quality 78.9 / Tier B, Medium-High risk and valuation confidence 55/100 are the active fundamental assessments. Actual live price-based classifications, rankings and Opportunity Scores belong to FolioFacts.


Material Sources

Source Type Date / Period What It Supports
MIAX Q3 2026 earnings release Company IR Q3 2026 Financial results, segment results, share, volume, guidance, cash and debt
MIAX Q3 2026 Form 10-Q SEC filing 2026-09-30 Nine-month cash flow, SBC, share counts, nonrecurring GAAP items, capitalization
MIAX Q2 2026 Form 10-Q SEC filing 2026-06-30 Six-month cash-flow statement, capital spending, software capitalization, and SBC supporting derived Q3 FCF
MIAX Q3 2026 earnings call Q&A transcript via Quartr 2026-10-29 Analyst questions, RPC bridge, future subsidies, technology/competition
MIAX binary index and KPI options announcement Company IR 2026-11-03 Proposed products, SEC-review dependency and timing
MIAX historical prices Market-data reference 2026-11-04 $34.97 regular-session close
MIAX statistics — StockAnalysis/S&P Market-data research reference 2026-11-04 Capitalization and multiples cross-check
Cboe statistics — StockAnalysis/S&P Comparable research reference 2026-11-04 Exchange multiple cross-check
ICE statistics — StockAnalysis/S&P Comparable research reference 2026-11-04 Exchange multiple cross-check
Nasdaq statistics — StockAnalysis/S&P Comparable research reference 2026-11-04 Exchange multiple cross-check
CME statistics — StockAnalysis/S&P Comparable research reference 2026-11-04 Futures network/multiple cross-check
MIAX Q2 2026 earnings release Company IR Q2 / H1 2026 Prior operating baseline
MIAX Q2 2026 earnings-call transcript Historical Q&A 2026-08-05 Preceding analyst debates
MIAX September trading statistics Company IR September 2026 Earlier YTD share and ADV
MIAX 2025 Form 10-K SEC filing FY2025 Annual business and historical results
MIAX Dorman OCC membership Company IR 2026-09-24 FCM distribution/clearing infrastructure
SEC XBRL company facts — MIAX Regulatory filing (as tagged) FY2026, through 2026-09-30 Current-year standalone-quarter and year-to-date source facts for FCF, SBC, revenue and other reported metrics

Third-party market-data figures are dated research verification references, not licensed public redistribution feeds. Model estimates and scenario probabilities are independent research.

This page presents the saved MIAX analysis. Ratings, zones, and opportunity scores shown above are recalculated at its dated reference price using FolioFacts rules; the live Creator Watchlist uses current market prices and can differ. Missing financial data is not estimated.

Edit company

Prices are entered manually. Changing this company's price updates all your positions in it and the valuation calculations in your private Watchlist and Insights. Shares and average cost stay specific to each position.

COMPANY ANALYSIS

Included accounts

PORTFOLIO EXPORT

Export holdings

Company Overrides

Your estimates, applied across your portfolio and watchlist. These companies have saved research overrides.

How to configure overrides
  1. In Watchlist, find the company and select Edit. Add it first if needed.
  2. Check its investment type, price and price date in Company details.
  3. Open Research overrides to enter fair value, quality, price zones or scenarios, then select Save changes.

Leave fields blank to use available report values. Add your thesis or sources in Notes.

YOUR EXPERIENCE MATTERS

Help improve FolioFacts.

Found a problem or have an idea? Tell us what would make FolioFacts more useful to you.

Please leave out account numbers, balances and other sensitive information. Feedback is private to the site administrator and kept for up to 90 days. Privacy policy